Press Releases 2012
Boston Scientific WATCHMAN™ Left Atrial Appendage Closure Device Receives CE Mark Approval For Expanded Use - Aug 26, 2012
European regulators have approved an expanded indication for the Boston Scientific Corporation (NYSE: BSX) WATCHMAN® Left Atrial Appendage (LAA) Closure Device. The new indication...
Boston Scientific Completes Patient Enrollment in PREVAIL Study for First-in-Class WATCHMAN Device - Jul 02, 2012
Boston Scientific Corporation (NYSE: BSX) has completed enrollment in the PREVAIL confirmatory study, designed to gain U.S. Food and Drug Administration (FDA) approval for the...
Media Contacts
Rosie Ireland
Corporate Communications
+44 7585403359
rosie.ireland@bsci.com